ID   HYCCI_HUMAN             Reviewed;         521 AA.
AC   Q9BYI3; A0A024RA06; A4D145; B8ZZJ1; Q6N010; Q75MR4; Q7LDZ4; Q96MX1; Q96NQ6;
DT   11-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   07-APR-2021, entry version 138.
DE   RecName: Full=Hyccin {ECO:0000303|PubMed:16951682};
DE   AltName: Full=Down-regulated by CTNNB1 protein A {ECO:0000303|PubMed:10910037};
DE   AltName: Full=Protein FAM126A {ECO:0000305};
GN   Name=FAM126A; Synonyms=DRCTNNB1A {ECO:0000303|PubMed:10910037};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), POSSIBLE FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Fetal brain;
RX   PubMed=10910037;
RA   Kawasoe T., Furukawa Y., Daigo Y., Nishiwaki T., Ishiguro H., Fujita M.,
RA   Satoh S., Miwa N., Nagasawa Y., Miyoshi Y., Ogawa M., Nakamura Y.;
RT   "Isolation and characterization of a novel human gene, DRCTNNB1A, the
RT   expression of which is down-regulated by beta-catenin.";
RL   Cancer Res. 60:3354-3358(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread expansion of protein interaction capabilities by alternative
RT   splicing.";
RL   Cell 0:0-0(2016).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-453, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [10]
RP   INVOLVEMENT IN HLD5.
RX   PubMed=21911699; DOI=10.1001/archneurol.2011.201;
RA   Biancheri R., Zara F., Rossi A., Mathot M., Nassogne M.C., Yalcinkaya C.,
RA   Erturk O., Tuysuz B., Di Rocco M., Gazzerro E., Bugiani M.,
RA   van Spaendonk R., Sistermans E.A., Minetti C., van der Knaap M.S.,
RA   Wolf N.I.;
RT   "Hypomyelination and congenital cataract: broadening the clinical
RT   phenotype.";
RL   Arch. Neurol. 68:1191-1194(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-306; SER-415; SER-422;
RP   SER-433 AND SER-453, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 12-271 IN COMPLEX WITH TTC7B,
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH TTC7B, IDENTIFICATION IN
RP   THE PI4K COMPLEX, AND CHARACTERIZATION OF VARIANTS HLD5 PRO-53 AND ARG-57.
RX   PubMed=26571211; DOI=10.1038/ncb3271;
RA   Baskin J.M., Wu X., Christiano R., Oh M.S., Schauder C.M., Gazzerro E.,
RA   Messa M., Baldassari S., Assereto S., Biancheri R., Zara F., Minetti C.,
RA   Raimondi A., Simons M., Walther T.C., Reinisch K.M., De Camilli P.;
RT   "The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis
RT   at the plasma membrane.";
RL   Nat. Cell Biol. 18:132-138(2016).
RN   [13]
RP   VARIANT HLD5 PRO-53, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16951682; DOI=10.1038/ng1870;
RA   Zara F., Biancheri R., Bruno C., Bordo L., Assereto S., Gazzerro E.,
RA   Sotgia F., Wang X.B., Gianotti S., Stringara S., Pedemonte M., Uziel G.,
RA   Rossi A., Schenone A., Tortori-Donati P., van der Knaap M.S., Lisanti M.P.,
RA   Minetti C.;
RT   "Deficiency of hyccin, a newly identified membrane protein, causes
RT   hypomyelination and congenital cataract.";
RL   Nat. Genet. 38:1111-1113(2006).
RN   [14]
RP   VARIANT HLD5 ARG-57.
RX   PubMed=23998934; DOI=10.1016/j.bbrc.2013.08.077;
RA   Traverso M., Assereto S., Gazzerro E., Savasta S., Abdalla E.M., Rossi A.,
RA   Baldassari S., Fruscione F., Ruffinazzi G., Fassad M.R., El Beheiry A.,
RA   Minetti C., Zara F., Biancheri R.;
RT   "Novel FAM126A mutations in hypomyelination and congenital cataract
RT   disease.";
RL   Biochem. Biophys. Res. Commun. 439:369-372(2013).
RN   [15]
RP   VARIANT GLN-217.
RX   PubMed=28887846; DOI=10.1002/humu.23335;
RA   Zhou X.L., He L.X., Yu L.J., Wang Y., Wang X.J., Wang E.D., Yang T.;
RT   "Mutations in KARS cause early-onset hearing loss and leukoencephalopathy:
RT   Potential pathogenic mechanism.";
RL   Hum. Mutat. 38:1740-1750(2017).
CC   -!- FUNCTION: Component of a complex required to localize
CC       phosphatidylinositol 4-kinase (PI4K) to the plasma membrane
CC       (PubMed:26571211). The complex acts as a regulator of
CC       phosphatidylinositol 4-phosphate (PtdIns(4)P) synthesis
CC       (PubMed:26571211). FAM126A plays a key role in oligodendrocytes
CC       formation, a cell type with expanded plasma membrane that requires
CC       generation of PtdIns(4)P (PubMed:26571211). Its role in
CC       oligodendrocytes formation probably explains its importance in
CC       myelination of the central and peripheral nervous system
CC       (PubMed:26571211, PubMed:16951682). May also have a role in the beta-
CC       catenin/Lef signaling pathway (Probable). {ECO:0000269|PubMed:16951682,
CC       ECO:0000269|PubMed:26571211, ECO:0000305|PubMed:10910037}.
CC   -!- SUBUNIT: Component of a phosphatidylinositol 4-kinase (PI4K) complex,
CC       composed of PI4KA, EFR3 (EFR3A or EFR3B), TTC7 (TTC7A or TTC7B) and
CC       FAM126 (FAM126A or FAM126B) (PubMed:26571211). Interacts with TTC7
CC       (TTC7A or TTC7B), interaction is direct (PubMed:26571211).
CC       {ECO:0000269|PubMed:26571211}.
CC   -!- INTERACTION:
CC       Q9BYI3; O95273: CCNDBP1; NbExp=3; IntAct=EBI-11065686, EBI-748961;
CC       Q9BYI3; Q13643: FHL3; NbExp=3; IntAct=EBI-11065686, EBI-741101;
CC       Q9BYI3; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-11065686, EBI-16439278;
CC       Q9BYI3; P14373: TRIM27; NbExp=6; IntAct=EBI-11065686, EBI-719493;
CC       Q9BYI3; Q86TV6: TTC7B; NbExp=5; IntAct=EBI-11065686, EBI-12006098;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10910037,
CC       ECO:0000269|PubMed:26571211}. Cell membrane
CC       {ECO:0000269|PubMed:16951682, ECO:0000269|PubMed:26571211}.
CC       Note=Localizes to the cytosol and is recruited to the plasma membrane
CC       following interaction with other components of the phosphatidylinositol
CC       4-kinase (PI4K) complex. {ECO:0000269|PubMed:26571211}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BYI3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BYI3-2; Sequence=VSP_023126;
CC       Name=3;
CC         IsoId=Q9BYI3-3; Sequence=VSP_058128, VSP_058129;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highest levels in heart, brain,
CC       placenta, spleen and testis. {ECO:0000269|PubMed:10910037}.
CC   -!- INDUCTION: Down-regulated by beta-catenin.
CC       {ECO:0000269|PubMed:10910037}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 5 (HLD5) [MIM:610532]: A
CC       hypomyelinating leukodystrophy associated with congenital cataract. It
CC       is clinically characterized by congenital cataract, progressive
CC       neurologic impairment, and diffuse myelin deficiency. Affected
CC       individuals experience progressive pyramidal and cerebellar
CC       dysfunction, muscle weakness and wasting prevailingly in the lower
CC       limbs. Mental deficiency ranges from mild to moderate. HLD5 shows
CC       clinical variability, but features of hypomyelination combined with
CC       increased periventricular white matter water content are consistently
CC       observed. {ECO:0000269|PubMed:16951682, ECO:0000269|PubMed:21911699,
CC       ECO:0000269|PubMed:23998934, ECO:0000269|PubMed:26571211}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the FAM126 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB030241; BAB39849.1; -; mRNA.
DR   EMBL; KU178808; ALQ34266.1; -; mRNA.
DR   EMBL; KU178809; ALQ34267.1; -; mRNA.
DR   EMBL; AK056319; BAB71148.1; -; mRNA.
DR   EMBL; AK054887; BAB70823.1; -; mRNA.
DR   EMBL; AC005682; AAS01991.1; -; Genomic_DNA.
DR   EMBL; AC006039; AAS07519.1; -; Genomic_DNA.
DR   EMBL; CH236948; EAL24262.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93767.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93768.1; -; Genomic_DNA.
DR   EMBL; BC018710; AAH18710.1; -; mRNA.
DR   EMBL; BX640757; CAE45864.1; -; mRNA.
DR   CCDS; CCDS5377.1; -. [Q9BYI3-1]
DR   CCDS; CCDS87486.1; -. [Q9BYI3-3]
DR   RefSeq; NP_115970.2; NM_032581.3. [Q9BYI3-1]
DR   RefSeq; XP_005249951.1; XM_005249894.3.
DR   RefSeq; XP_011513891.1; XM_011515589.2. [Q9BYI3-1]
DR   PDB; 5DSE; X-ray; 2.90 A; B/D=2-308.
DR   PDB; 6BQ1; EM; 3.60 A; C/G=2-289.
DR   PDBsum; 5DSE; -.
DR   PDBsum; 6BQ1; -.
DR   SMR; Q9BYI3; -.
DR   BioGRID; 124188; 22.
DR   CORUM; Q9BYI3; -.
DR   IntAct; Q9BYI3; 14.
DR   STRING; 9606.ENSP00000403396; -.
DR   iPTMnet; Q9BYI3; -.
DR   PhosphoSitePlus; Q9BYI3; -.
DR   BioMuta; FAM126A; -.
DR   DMDM; 77416421; -.
DR   EPD; Q9BYI3; -.
DR   jPOST; Q9BYI3; -.
DR   MassIVE; Q9BYI3; -.
DR   MaxQB; Q9BYI3; -.
DR   PaxDb; Q9BYI3; -.
DR   PeptideAtlas; Q9BYI3; -.
DR   PRIDE; Q9BYI3; -.
DR   ProteomicsDB; 7387; -.
DR   ProteomicsDB; 79652; -. [Q9BYI3-1]
DR   ProteomicsDB; 79653; -. [Q9BYI3-2]
DR   Antibodypedia; 53361; 62 antibodies.
DR   DNASU; 84668; -.
DR   Ensembl; ENST00000409923; ENSP00000386246; ENSG00000122591. [Q9BYI3-3]
DR   Ensembl; ENST00000432176; ENSP00000403396; ENSG00000122591. [Q9BYI3-1]
DR   GeneID; 84668; -.
DR   KEGG; hsa:84668; -.
DR   UCSC; uc003svm.5; human. [Q9BYI3-1]
DR   UCSC; uc064byk.1; human.
DR   CTD; 84668; -.
DR   DisGeNET; 84668; -.
DR   GeneCards; FAM126A; -.
DR   GeneReviews; FAM126A; -.
DR   HGNC; HGNC:24587; FAM126A.
DR   HPA; ENSG00000122591; Low tissue specificity.
DR   MalaCards; FAM126A; -.
DR   MIM; 610531; gene.
DR   MIM; 610532; phenotype.
DR   neXtProt; NX_Q9BYI3; -.
DR   OpenTargets; ENSG00000122591; -.
DR   Orphanet; 85163; Hypomyelination-congenital cataract syndrome.
DR   PharmGKB; PA162385852; -.
DR   VEuPathDB; HostDB:ENSG00000122591.11; -.
DR   eggNOG; KOG4688; Eukaryota.
DR   GeneTree; ENSGT00390000011295; -.
DR   HOGENOM; CLU_027457_3_0_1; -.
DR   InParanoid; Q9BYI3; -.
DR   OMA; NRATYEM; -.
DR   OrthoDB; 673408at2759; -.
DR   PhylomeDB; Q9BYI3; -.
DR   TreeFam; TF317153; -.
DR   PathwayCommons; Q9BYI3; -.
DR   BioGRID-ORCS; 84668; 8 hits in 1003 CRISPR screens.
DR   ChiTaRS; FAM126A; human.
DR   GenomeRNAi; 84668; -.
DR   Pharos; Q9BYI3; Tbio.
DR   PRO; PR:Q9BYI3; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9BYI3; protein.
DR   Bgee; ENSG00000122591; Expressed in gastrocnemius and 214 other tissues.
DR   ExpressionAtlas; Q9BYI3; baseline and differential.
DR   Genevisible; Q9BYI3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042552; P:myelination; ISS:UniProtKB.
DR   GO; GO:0046854; P:phosphatidylinositol phosphorylation; IDA:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   InterPro; IPR018619; Hyccin.
DR   PANTHER; PTHR31220; PTHR31220; 1.
DR   Pfam; PF09790; Hyccin; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cataract; Cell membrane; Cytoplasm;
KW   Disease variant; Leukodystrophy; Membrane; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..521
FT                   /note="Hyccin"
FT                   /id="PRO_0000080005"
FT   MOD_RES         306
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6P9N1"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..341
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_023126"
FT   VAR_SEQ         331..419
FT                   /note="GNTELTGQEELMEISEVDEGFYSRAASSTSQSGLSNSSHNCSNKPSIGKNHR
FT                   RSGGSKTGGKEKETTGESCKDHFARKQTQRAQSENLE -> EQPDNNNDATELGILVIP
FT                   EISVTNVAGERTGNGEKGRTLGEIDAQHIQGVQETATDPRTESKGLPEIRRQKSVRKMM
FT                   EDGINSPGRVQF (in isoform 3)"
FT                   /id="VSP_058128"
FT   VAR_SEQ         420..521
FT                   /note="Missing (in isoform 3)"
FT                   /id="VSP_058129"
FT   VARIANT         53
FT                   /note="L -> P (in HLD5; induces misfolding and degradation,
FT                   leading to destabilization of the PI4K complex;
FT                   dbSNP:rs72549407)"
FT                   /evidence="ECO:0000269|PubMed:16951682,
FT                   ECO:0000269|PubMed:26571211"
FT                   /id="VAR_030647"
FT   VARIANT         57
FT                   /note="C -> R (in HLD5; induces misfolding and degradation,
FT                   leading to destabilization of the PI4K complex)"
FT                   /evidence="ECO:0000269|PubMed:23998934,
FT                   ECO:0000269|PubMed:26571211"
FT                   /id="VAR_075100"
FT   VARIANT         217
FT                   /note="R -> Q (in dbSNP:rs192409840)"
FT                   /evidence="ECO:0000269|PubMed:28887846"
FT                   /id="VAR_079751"
FT   CONFLICT        160
FT                   /note="V -> A (in Ref. 1; BAB39849)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        194
FT                   /note="Y -> C (in Ref. 1; BAB39849)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        474
FT                   /note="A -> V (in Ref. 4; CAE45864)"
FT                   /evidence="ECO:0000305"
FT   HELIX           8..14
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   TURN            26..28
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           37..46
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           54..65
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           69..76
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           79..91
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           100..112
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   STRAND          116..119
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   STRAND          123..126
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           144..147
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   STRAND          159..163
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           176..190
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           197..212
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           217..221
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           234..248
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   TURN            249..251
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           253..269
FT                   /evidence="ECO:0007744|PDB:5DSE"
FT   HELIX           273..285
FT                   /evidence="ECO:0007744|PDB:5DSE"
SQ   SEQUENCE   521 AA;  57625 MW;  722D7A9CFD5EC060 CRC64;
     MFTSEKGVVE EWLSEFKTLP ETSLPNYATN LKDKSSLVSS LYKVIQEPQS ELLEPVCHQL
     FEFYRSGEEQ LLQFTLQFLP ELIWCYLAVS ASRNVHSSGC IEALLLGVYN LEIVDKQGHT
     KVLSFTIPSL SKPSVYHEPS SIGSMALTES ALSQHGLSKV VYSGPHPQRE MLTAQNRFEV
     LTFLLLCYNA ALTYMPSVSL QSLCQICSRI CVCGYPRQHV RKYKGISSRI PVSSGFMVQM
     LTGIYFAFYN GEWDLAQKAL DDIIYRAQLE LYPEPLLVAN AIKASLPHGP MKSNKEGTRC
     IQVEITPTSS RISRNAVTSM SIRGHRWKRH GNTELTGQEE LMEISEVDEG FYSRAASSTS
     QSGLSNSSHN CSNKPSIGKN HRRSGGSKTG GKEKETTGES CKDHFARKQT QRAQSENLEL
     LSLKRLTLTT SQSLPKPSSH GLAKTAATVF SKSFEQVSGV TVPHNPSSAV GCGAGTDANR
     FSACSLQEEK LIYVSERTEL PMKHQSGQQR PPSISITLST D
//
